337 related articles for article (PubMed ID: 12799554)
1. Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy.
Nolan D; Hammond E; Martin A; Taylor L; Herrmann S; McKinnon E; Metcalf C; Latham B; Mallal S
AIDS; 2003 Jun; 17(9):1329-38. PubMed ID: 12799554
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial DNA depletion in adipose tissue of HIV-infected patients with peripheral lipoatrophy.
Buffet M; Schwarzinger M; Amellal B; Gourlain K; Bui P; Prévot M; Deleuze J; Morini JP; Gorin I; Calvez V; Dupin N
J Clin Virol; 2005 May; 33(1):60-4. PubMed ID: 15797366
[TBL] [Abstract][Full Text] [Related]
3. Contribution of nucleoside-analogue reverse transcriptase inhibitor therapy to lipoatrophy from the population to the cellular level.
Nolan D; Hammond E; James I; McKinnon E; Mallal S
Antivir Ther; 2003 Dec; 8(6):617-26. PubMed ID: 14760896
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial proliferation, DNA depletion and adipocyte differentiation in subcutaneous adipose tissue of HIV-positive HAART recipients.
Pace CS; Martin AM; Hammond EL; Mamotte CD; Nolan DA; Mallal SA
Antivir Ther; 2003 Aug; 8(4):323-31. PubMed ID: 14518702
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial DNA depletion and respiratory chain activity in primary human subcutaneous adipocytes treated with nucleoside analogue reverse transcriptase inhibitors.
Stankov MV; Lücke T; Das AM; Schmidt RE; Behrens GM
Antimicrob Agents Chemother; 2010 Jan; 54(1):280-7. PubMed ID: 19805555
[TBL] [Abstract][Full Text] [Related]
6. Evidence of nucleoside analogue reverse transcriptase inhibitor--associated genetic and structural defects of mitochondria in adipose tissue of HIV-infected patients.
Walker UA; Bickel M; Lütke Volksbeck SI; Ketelsen UP; Schöfer H; Setzer B; Venhoff N; Rickerts V; Staszewski S
J Acquir Immune Defic Syndr; 2002 Feb; 29(2):117-21. PubMed ID: 11832679
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of lipoatrophy and mitochondrial DNA content of blood and subcutaneous fat in HIV-1-infected patients randomly allocated to zidovudine- or stavudine-based therapy.
van der Valk M; Casula M; Weverlingz GJ; van Kuijk K; van Eck-Smit B; Hulsebosch HJ; Nieuwkerk P; van Eeden A; Brinkman K; Lange J; de Ronde A; Reiss P
Antivir Ther; 2004 Jun; 9(3):385-93. PubMed ID: 15259901
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial DNA levels of peripheral blood mononuclear cells and subcutaneous adipose tissue from thigh, fat and abdomen of HIV-1 seropositive and negative individuals.
Gerschenson M; Shiramizu B; LiButti DE; Shikuma CM
Antivir Ther; 2005; 10 Suppl 2():M83-9. PubMed ID: 16152709
[TBL] [Abstract][Full Text] [Related]
9. Assessment of adipokine expression and mitochondrial toxicity in HIV patients with lipoatrophy on stavudine- and zidovudine-containing regimens.
Jones SP; Qazi N; Morelese J; Lebrecht D; Sutinen J; Yki-Jărvinen H; Back DJ; Pirmohamed M; Gazzard BG; Walker UA; Moyle GJ
J Acquir Immune Defic Syndr; 2005 Dec; 40(5):565-72. PubMed ID: 16284533
[TBL] [Abstract][Full Text] [Related]
10. Changes in the peripheral blood mtDNA levels in naive patients treated by different nucleoside reverse transcriptase inhibitor combinations and their association with subsequent lipodystrophy.
Chêne G; Amellal B; Pédrono G; Gourlain K; Rancinan C; Journot V; Cotte L; Palmer P; Castro ND; Calvez V; Molina JM;
AIDS Res Hum Retroviruses; 2007 Jan; 23(1):54-61. PubMed ID: 17263633
[TBL] [Abstract][Full Text] [Related]
11. Depletion of mitochondrial DNA copies/cell in peripheral blood mononuclear cells in HIV-1-infected treatment-naïve patients.
Maagaard A; Holberg-Petersen M; Kvittingen EA; Sandvik L; Bruun JN
HIV Med; 2006 Jan; 7(1):53-8. PubMed ID: 16313293
[TBL] [Abstract][Full Text] [Related]
12. Accumulation of mitochondrial DNA mutations in human immunodeficiency virus-infected patients treated with nucleoside-analogue reverse-transcriptase inhibitors.
Martin AM; Hammond E; Nolan D; Pace C; Den Boer M; Taylor L; Moore H; Martinez OP; Christiansen FT; Mallal S
Am J Hum Genet; 2003 Mar; 72(3):549-60. PubMed ID: 12587093
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial DNA decrease in subcutaneous adipose tissue of HIV-infected individuals with peripheral lipoatrophy.
Shikuma CM; Hu N; Milne C; Yost F; Waslien C; Shimizu S; Shiramizu B
AIDS; 2001 Sep; 15(14):1801-9. PubMed ID: 11579242
[TBL] [Abstract][Full Text] [Related]
14. Relationship of mitochondrial DNA depletion and respiratory chain activity in preadipocytes treated with nucleoside reverse transcriptase inhibitors.
Stankov MV; Lücke T; Das AM; Schmidt RE; Behrens GM;
Antivir Ther; 2007; 12(2):205-16. PubMed ID: 17503663
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial (mt)DNA changes in tissue may not be reflected by depletion of mtDNA in peripheral blood mononuclear cells in HIV-infected patients.
Maagaard A; Holberg-Petersen M; Kollberg G; Oldfors A; Sandvik L; Bruun JN
Antivir Ther; 2006; 11(5):601-8. PubMed ID: 16964828
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial DNA content of peripheral blood mononuclear cells in ART untreated & stavudine/zidovudine treated HIV-1-infected patients.
Subashini D; Dinesha TR; Srirama RB; Boobalan J; Poongulali S; Chitra DA; Mothi SN; Solomon SS; Saravanan S; Solomon S; Balakrishnan P
Indian J Med Res; 2018 Aug; 148(2):207-214. PubMed ID: 30381544
[TBL] [Abstract][Full Text] [Related]
17. Depleted skeletal muscle mitochondrial DNA, hyperlactatemia, and decreased oxidative capacity in HIV-infected patients on highly active antiretroviral therapy.
Haugaard SB; Andersen O; Pedersen SB; Dela F; Richelsen B; Nielsen JO; Madsbad S; Iversen J
J Med Virol; 2005 Sep; 77(1):29-38. PubMed ID: 16032748
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial DNA assessment in adipocytes and peripheral blood mononuclear cells of HIV-infected patients with lipodystrophy according to a validated case definition.
Casula M; van der Valk M; Wit FW; Nievaard MA; Reiss P
HIV Med; 2007 Jan; 8(1):32-7. PubMed ID: 17305930
[TBL] [Abstract][Full Text] [Related]
19. Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy: results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA).
Negredo E; Miró O; Rodríguez-Santiago B; Garrabou G; Estany C; Masabeu A; Force L; Barrufet P; Cucurull J; Domingo P; Alonso-Villaverde C; Bonjoch A; Morén C; Pérez-Alvarez N; Clotet B;
Clin Infect Dis; 2009 Sep; 49(6):892-900. PubMed ID: 19663689
[TBL] [Abstract][Full Text] [Related]
20. Gene expression and immunohistochemistry in adipose tissue of HIV type 1-infected patients with nucleoside analogue reverse-transcriptase inhibitor-associated lipoatrophy.
Sievers M; Walker UA; Sevastianova K; Setzer B; Wågsäter D; Eriksson P; Yki-Järvinen H; Sutinen J
J Infect Dis; 2009 Jul; 200(2):252-62. PubMed ID: 19519254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
